Trade AbbVie ^ABBV

Investors Buy Large Volume of AbbVie Call Options (NYSE:ABBV)

AbbVie (ABBV) Stock: Rises as RINVOQ Wins EU Approval for Severe Hair Loss

AbbVie Gets Europe OK for Rinvoq in Vitiligo, Alopecia Areata | Morningstar

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo | Morningstar

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata | Morningstar

AbbVie Secures EU Approval for Rinvoq to Treat Severe Alopecia Areata

AbbVie Wins EC Approval For Rinvoq In Non-Segmental Vitiligo

AbbVie Inc. $ABBV Shares Bought by Opal Capital LLC

AbbVie (ABBV) Expected to Announce Quarterly Earnings on Friday - Zolmax

Encore Global Management LP Takes $544,000 Position in AbbVie Inc. $ABBV

AbbVie (ABBV) Stock May Be Mispriced On Its 172% Run

AbbVie Secures EC Nod For RINVOQ In Severe Alopecia Areata

Amundi Has $2.33 Billion Holdings in AbbVie Inc. $ABBV

Pharmaceutical Stocks To Add to Your Watchlist - July 28th - Stock Observer

AbbVie Inc. $ABBV Shares Acquired by Lazard Asset Management LLC - Stock Observer

Encore Global Management LP Invests $544,000 in AbbVie Inc. $ABBV - Stock Observer

California State Teachers Retirement System Sells 62,377 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer

Goldman Sachs uncovers key AbbVie stock signals before earnings

De-escalation trials in multiple myeloma: past, present and future

AbbVie (NYSE:ABBV) Trading 2.6% Higher - What's Next?

3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st

Pharmaceutical Stocks To Add to Your Watchlist - July 28th - Daily Political

Empowered Funds LLC Acquires 78,374 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie (ABBV) Launches Boey In Europe With A Different Take On Wrinkle Injectables

Johnson & Johnson (NYSE:JNJ) Trading 1.1% Higher - Should You Buy? - Markets Daily

The Engine Behind ABBV Stock Has Real Parts

Johnson & Johnson (NYSE:JNJ) Shares Up 1.1% - Here's What Happened - Stock Observer

Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck

AbbVie (NYSE:ABBV) Sets New 12-Month High - Here's What Happened - Markets Daily

Gabelli Funds LLC Sells 25,600 Shares of AbbVie Inc. $ABBV

OMERS ADMINISTRATION Corp Grows Position in AbbVie Inc. $ABBV

Lombard Odier Asset Management Switzerland SA Grows Stock Position in AbbVie Inc. $ABBV - Zolmax

Lombard Odier Asset Management Switzerland SA Buys 6,900 Shares of AbbVie Inc. $ABBV - Markets Daily

Waverly Advisors LLC Purchases 5,800 Shares of AbbVie Inc. $ABBV

Best Pharmaceutical Stocks To Watch Now - July 25th

AbbVie (ABBV) Misses Key Phase 3 Survival Goal For Epcoritamab In DLBCL

Hilltop Holdings Inc. Has $6.51 Million Stock Holdings in AbbVie Inc. $ABBV - Zolmax

Epoch Investment Partners Inc. Has $327.57 Million Stock Position in AbbVie Inc. $ABBV

Dai ichi Life Insurance Company Ltd Decreases Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

Cannell & Spears LLC Decreases Holdings in AbbVie Inc. $ABBV - Daily Political

GC Wealth Management RIA LLC Lowers Stake in AbbVie Inc. $ABBV - Markets Daily

Gibbs Wealth Management Grows Position in AbbVie Inc. $ABBV

Dickmeyer Boyce Financial Management Inc. Acquires New Stake in AbbVie Inc. $ABBV - Markets Daily

Bank of Nova Scotia Cuts Stock Position in AbbVie Inc. $ABBV

glenmark: Glenmark Chief on Cracking the Multi-Specific Code | The Economic Times Podcast

AbbVie (ABBV) Expected to Release Earnings on Friday

Genmab, AbbVie Say Lymphoma Drug Failed to Meet Primary Endpoint in Phase 3 Trial | Morningstar

AbbVie (NYSE:ABBV) Trading Up 1.4% Following Analyst Upgrade

HDV Delivers 3.1% Yield While Beating SPY Year to Date by 9 Points

AbbVie (ABBV) Stock May Trade Above Fair Value Following Its 157% Run

I'd Double a Position in These 3 Dividend Stocks Right Now Without Any Hesitation - AOL

AbbVie, Allergan takes on Swiss aesthetics rival over syringe design

AbbVie Inc. $ABBV Shares Bought by Sei Investments Co.

Levin Capital Strategies L.P. Purchases Shares of 42,022 AbbVie Inc. $ABBV

NewEdge Wealth LLC Raises Stake in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. (NYSE:ABBV) Receives Consensus Recommendation of "Moderate Buy" from Analysts - Stock Observer

Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials

Canaccord Genuity Group Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock

Oslo Pensjonsforsikring AS Buys Shares of 6,115 AbbVie Inc. $ABBV - Zolmax

First Trust Advisors LP Has $330.58 Million Holdings in AbbVie Inc. $ABBV - Zolmax

AbbVie Inc. $ABBV Stock Position Boosted by First Trust Advisors LP

Danica Pension Livsforsikringsaktieselskab Takes $18.90 Million Position in AbbVie Inc. $ABBV - Zolmax

Bellwether Advisors LLC Boosts Stock Holdings in AbbVie Inc. $ABBV

Oslo Pensjonsforsikring AS Makes New $1.33 Million Investment in AbbVie Inc. $ABBV - Daily Political

PNC Financial Services Group Inc. Has $894.96 Million Holdings in AbbVie Inc. $ABBV - Daily Political

First Citizens Bank & Trust Co. Acquires 8,362 Shares of AbbVie Inc. $ABBV - Stock Observer

Madison Asset Management LLC Lowers Stake in AbbVie Inc. $ABBV - Daily Political

Chase Investment Counsel Corp Sells 5,299 Shares of AbbVie Inc. $ABBV - Daily Political

FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

AbbVie (NYSE:ABBV) Stock Price Up 1.1% - Still a Buy?

Analysts Set AbbVie Inc. (NYSE:ABBV) Target Price at $267.67 - Zolmax

Glenview Trust Co Buys 5,930 Shares of AbbVie Inc. $ABBV

Cura Wealth Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV

Commerzbank Aktiengesellschaft FI Decreases Stake in AbbVie Inc. $ABBV - Stock Observer

Glenview Trust Co Acquires 5,930 Shares of AbbVie Inc. $ABBV - Stock Observer

Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma

Pharmaceutical Stocks To Research - July 20th - Daily Political

KBC Group NV Makes New Investment in AbbVie Inc. $ABBV

ABBV Q2 2026 Earnings Report on 7/31/2026

AbbVie FY2027 EPS Estimate Increased by Erste Group Bank

Pharmaceutical Stocks To Follow Now - July 19th - Stock Observer

3 Biggest Pharma Giants: Buy, Sell or Hold?

How AbbVie's New Rapid-Onset Boey Toxin Could Reshape Aesthetics Demand for AbbVie (ABBV) Investors

946,326 Shares in AbbVie Inc. $ABBV Acquired by SEB Asset Management AB

AbbVie Inc. $ABBV Shares Bought by Mediolanum International Funds Ltd

Jennison Associates LLC Cuts Stake in AbbVie Inc. $ABBV - Daily Political

Pharmaceutical Stocks Worth Watching - July 18th - Stock Observer

Heartland Bank & Trust Co Purchases 5,308 Shares of AbbVie Inc. $ABBV - Markets Daily

Ranch Capital Advisors Inc. Raises Stake in AbbVie Inc. $ABBV

FSA Advisors Inc. Has $559,000 Stock Holdings in AbbVie Inc. $ABBV

26,081 Shares in AbbVie Inc. $ABBV Acquired by Independent Financial Group LLC - Markets Daily

Ranch Capital Advisors Inc. Purchases 4,017 Shares of AbbVie Inc. $ABBV - Stock Observer

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Fed, ECB & BoJ in action

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk